Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
341.12
-25.73 (-7.01%)
At close: Jul 31, 2026, 4:00 PM EDT
340.00
-1.12 (-0.33%)
After-hours: Jul 31, 2026, 7:40 PM EDT
Krystal Biotech Market Cap
Krystal Biotech has a market cap or net worth of $10.06 billion as of July 31, 2026. Its market cap has increased by 127.11% in one year.
Market Cap
10.06B
Enterprise Value
9.05B
1-Year Change
127.11%
Ranking
Category
Stock Price
$341.12
ChartMarket Cap Chart
Since September 20, 2017, Krystal Biotech's market cap has increased from $92.40M to $10.06B, an increase of 10,783.26%. That is a compound annual growth rate of 69.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 10.06B | 40.66% |
| Dec 31, 2025 | 7.15B | 58.67% |
| Dec 31, 2024 | 4.51B | 28.76% |
| Dec 29, 2023 | 3.50B | 71.56% |
| Dec 30, 2022 | 2.04B | 31.13% |
| Dec 31, 2021 | 1.56B | 31.54% |
| Dec 31, 2020 | 1.18B | 23.37% |
| Dec 31, 2019 | 958.50M | 219.71% |
| Dec 31, 2018 | 299.80M | 178.37% |
| Dec 29, 2017 | 107.70M | 16.56% |
| Sep 20, 2017 | 92.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Madrigal Pharmaceuticals | 12.61B |
| Arrowhead Pharmaceuticals | 12.14B |
| BioMarin Pharmaceutical | 11.86B |
| Axsome Therapeutics | 11.70B |
| Bio-Techne | 11.22B |
| Cytokinetics | 10.64B |
| ABIVAX Société Anonyme | 10.63B |
| Summit Therapeutics | 10.21B |